GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,181,000 | -19.3% | 31,160 | 0.0% | 1.03% | +8.4% |
| Q4 2019 | $1,464,000 | +10.1% | 31,160 | 0.0% | 0.95% | +5.1% |
| Q3 2019 | $1,330,000 | +6.7% | 31,160 | 0.0% | 0.90% | +10.5% |
| Q2 2019 | $1,247,000 | -4.2% | 31,160 | 0.0% | 0.82% | -5.1% |
| Q1 2019 | $1,302,000 | +12.0% | 31,160 | +2.5% | 0.86% | +7.6% |
| Q4 2018 | $1,162,000 | -0.8% | 30,410 | +4.4% | 0.80% | +6.5% |
| Q3 2018 | $1,171,000 | – | 29,140 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |